Back to Agenda
Live Oral Poster Presentations III
Learning Objective : •Provide an understanding of the climate impact of clinical research •Discuss opportunities to develop a more robust understanding of key sources of greenhouse emissions in our trials, and create opportunities for benchmarking and sharing of best practices •Provide insights into how we can position sustainability to co-inform clinical trial design based on real world experiences of trial sponsor
Speaker(s)
Ensuring the Benefits of Our Therapies are not Offset by Our Operations: Reducing the Climate Impact of Clinical Research
Jason LaRoche, MSc
Johnson & Johnson Innovative Medicines, Netherlands
Director, Innovative Health
Megan Heath, PhD
Sanofi, United Kingdom
Head of Clinical Study Units Europe Region
Towards Equitable Participation in Oncology Trials: Evaluating Eligibility-Based Representativeness for Black Patients
Corey Michael Benedum, PhD, MPH
Flatiron Health, United States
Quantitative Scientist
![Lidewij Eva Vat, DrSc, MS](/_Images/member/Generic_Image_Missing-Profile.jpg)
Lidewij Eva Vat, DrSc, MS
The Synergist, Netherlands
Program Director
Bringing eConsent to the Place it Deserves through Harmonizing and Insights in Value Models
Hilde Vanaken, PhD, MSc
EFGCP, TCS, Belgium
Head, European Forum GCP (EFGCP) eConsent Initiative, Head TCS Industry Leaders
![Sini Eskola, MPharm, MSc](/_Images/member/Generic_Image_Missing-Profile.jpg)
Systematic review of externally controlled (EC) trials, data used in them, and their role in regulatory decision-making
Sini Eskola, MPharm, MSc
University of Utrecht, Netherlands
PhD Candidate
Qualitative analysis of participant-entered free text data to inform good diary design
Saima Khakwani, MPH, MSc
Clario, United Kingdom
Clinical Science Associate
Lisa Ensign, PhD, MSc
Medidata, a Dassault Systemes Company, United States
VP, Statistics and Regulatory Science Innovation
Evaluating an algorithm for fit-for-purpose use in feature extraction of motor function in early-stage Parkinson’s disease.
J. Rubin Abrams, PhD
Critical Path Institute, United States
Quantitative Medicine Scientist
Isabelle Huys, PharmD, PhD, MPharm
KU Leuven, Belgium
Professor
Have an account?